Showing 20 of 86 recruiting trials for “squamous-cell-carcinoma-of-the-nasal-cavity-and-paranasal-sinuses”
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
👨⚕️ Matin Imanguli, JHU Sidney Kimmel Comprehensive Cancer Center LAO📍 3 sites📅 Started Aug 2026View details ↗
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ yuecan zeng, doctor, The Second Affiliated Hospital of Hainan Medical University📍 1 site📅 Started Feb 2026View details ↗
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
👨⚕️ Jiang D Sui, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07376603 ↗
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
RecruitingNCT07232680 ↗
Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
👨⚕️ Rodney Cheng En Hsieh, MD, PhD, Chang Gung Memorial Hospital📍 1 site📅 Started Nov 2025View details ↗
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
👨⚕️ Jennifer L Shah, University of Michigan Rogel Cancer Center📍 1 site📅 Started Jul 2025View details ↗
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
RecruitingNCT05837221 ↗
Microbiome in Head and Neck Squamous Cell Carcinoma
A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →